基本信息
views: 2
Career Trajectory
Bio
Dr. Rich has a career interest in understanding the causes and treatments of pulmonary hypertension. He was principle investigator for the NIH Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical center in the USA for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. This knowledge has lead to the discovery of more effective treatments for pulmonary hypertension, including the use of medicines like anticoagulants, calcium channel blockers, and prostacyclins. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.
Research Interests
Papers共 345 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CIRCULATION-HEART FAILUREno. 4 (2024): e011095-e011095
European journal of heart failureno. 4 (2024): 707-729
Journal of Cardiac Failureno. 4 (2023): 714-715
Research Square (Research Square) (2023)
M. Girardis,D. Bettex, M. Bojan, C. Demponeras,S. Fruhwald, J. Gál,H. V. Groesdonk,F. Guarracino, J. L. Guerrero-Orriach,M. Heringlake,A. Herpain, L. Heunks,
Journal of Anesthesia, Analgesia and Critical Careno. 1 (2022): 1-22
Journal of the American College of Cardiologyno. 18 (2022): 1858-1869
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn